Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA Replacement for Primary Adrenal Insufficiency
NCT00004313Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Aug 1995
- Modality
- Allosteric Modulators
01
Overview
A Phase 3 trial of dehydroepiandrosterone in primary adrenal insufficiency (PAI), sponsored by National Center for Research Resources. Started Aug 1995; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
primary adrenal insufficiency (PAI)
Beyond the preview
Go deeper on NCT00004313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004313.